J. Anand Subramony - Search Results

Year	Number of Results
1996	1
2006	2
2013	1
2016	2
2017	4
2018	4
2019	1
2020	1
2021	4
2022	1
2023	2
2024	0

1

Microprocessor controlled transdermal drug delivery.

Subramony JA, Sharma A, Phipps JB. Subramony JA, et al. Int J Pharm. 2006 Jul 6;317(1):1-6. doi: 10.1016/j.ijpharm.2006.03.053. Epub 2006 Apr 18. Int J Pharm. 2006. PMID: 16713690 Review.

2

Apomorphine in dopaminergic therapy.

Subramony JA. Subramony JA. Mol Pharm. 2006 Jul-Aug;3(4):380-5. doi: 10.1021/mp060012c. Mol Pharm. 2006. PMID: 16889431 Review.

3

Toward closed-loop drug delivery: Integrating wearable technologies with transdermal drug delivery systems.

Manikkath J, Subramony JA. Manikkath J, et al. Among authors: subramony ja. Adv Drug Deliv Rev. 2021 Dec;179:113997. doi: 10.1016/j.addr.2021.113997. Epub 2021 Oct 8. Adv Drug Deliv Rev. 2021. PMID: 34634396 Review.

4

Needle free parenteral drug delivery: leveraging active transdermal technologies for pediatric use.

Subramony JA. Subramony JA. Int J Pharm. 2013 Oct 15;455(1-2):14-8. doi: 10.1016/j.ijpharm.2013.07.055. Epub 2013 Jul 31. Int J Pharm. 2013. PMID: 23916825 Review.

5

Submicron Aggregation of Chemically Denatured Monoclonal Antibody.

Rowe JB, Flynn RP, Wooten HR, Noufer HA, Cancel RA, Zhang J, Subramony JA, Pechenov S, Wang Y. Rowe JB, et al. Among authors: subramony ja. Mol Pharm. 2018 Oct 1;15(10):4710-4721. doi: 10.1021/acs.molpharmaceut.8b00690. Epub 2018 Sep 5. Mol Pharm. 2018. PMID: 30142275

6

Nanotherapeutics in oral and parenteral drug delivery: Key learnings and future outlooks as we think small.

Tyagi P, Subramony JA. Tyagi P, et al. Among authors: subramony ja. J Control Release. 2018 Feb 28;272:159-168. doi: 10.1016/j.jconrel.2018.01.009. Epub 2018 Jan 19. J Control Release. 2018. PMID: 29355619 Review.

7

Improving drug-like properties of insulin and GLP-1 via molecule design and formulation and improving diabetes management with device & drug delivery.

Pechenov S, Bhattacharjee H, Yin D, Mittal S, Subramony JA. Pechenov S, et al. Among authors: subramony ja. Adv Drug Deliv Rev. 2017 Mar;112:106-122. doi: 10.1016/j.addr.2017.01.006. Epub 2017 Jan 30. Adv Drug Deliv Rev. 2017. PMID: 28153578 Review.

8

Evaluation of Pyrrolobenzodiazepine-Loaded Nanoparticles: A Targeted Drug Delivery Approach.

Tyagi P, Pechenov S, RiosDoria J, Masterson L, Dickinson NJ, Howard P, Mao S, Harper J, Wetzel L, Yo K, Subramony JA. Tyagi P, et al. Among authors: subramony ja. J Pharm Sci. 2019 Apr;108(4):1590-1597. doi: 10.1016/j.xphs.2018.11.023. Epub 2018 Nov 22. J Pharm Sci. 2019. PMID: 30472264

9

Targeted oral peptide delivery using multi-unit particulates: Drug and permeation enhancer layering approach.

Tyagi P, Trivedi R, Pechenov S, Patel C, Revell J, Wills S, Huang Y, Rosenbaum AI, Subramony JA. Tyagi P, et al. Among authors: subramony ja. J Control Release. 2021 Oct 10;338:784-791. doi: 10.1016/j.jconrel.2021.09.002. Epub 2021 Sep 6. J Control Release. 2021. PMID: 34499981

10

Sensitive Colorimetric Detection of Interleukin-6 via Lateral Flow Assay Incorporated Silver Amplification Method.

Rahbar M, Wu Y, Subramony JA, Liu G. Rahbar M, et al. Among authors: subramony ja. Front Bioeng Biotechnol. 2021 Nov 26;9:778269. doi: 10.3389/fbioe.2021.778269. eCollection 2021. Front Bioeng Biotechnol. 2021. PMID: 34900966 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

21 results

Results by year

Search Page

Filters

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

Search Results

21 results

Results by year